Unusual cancer types are frequently observed in a little quantity of sufferers, and sometimes no conventional 2nd-line therapy is prescribed. Due to their rarity, these malignancies in many cases are not researched in common phase 3 scientific trials to ascertain the worth of new treatment options.Scientists use single-cell NGS methods to check can